<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27092053</article-id>
<article-id pub-id-type="pmc">4820443</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2016.00089</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Guidotti</surname>
<given-names>Alessandro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/10307/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grayson</surname>
<given-names>Dennis R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/22915/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caruncho</surname>
<given-names>Hector J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Psychiatry, The Psychiatric Institute, College of Medicine, University of Illinois at Chicago</institution>
<country>Chicago, IL, USA</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Pharmacy and Nutrition, University of Saskatchewan</institution>
<country>Saskatoon, SK, Canada</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Gabriella D’Arcangelo, Rutgers, The State Univesity of New Jersey, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marija Kundakovic, Fordham University, USA; Tania L. Roth, University of Delaware, USA</p>
</fn>
<corresp id="fn001">*Correspondence: Alessandro Guidotti <email xlink:type="simple">aguidotti@psych.uic.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>10</volume>
<elocation-id>89</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>1</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Guidotti, Grayson and Caruncho.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Guidotti, Grayson and Caruncho</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>REELIN (RELN) is a large (420 kDa) glycoprotein that in adulthood is mostly synthesized in GABAergic neurons of corticolimbic structures. Upon secretion in the extracellular matrix (ECM), RELN binds to VLDL, APOE2, and α3β2 Integrin receptors located on dendritic shafts and spines of postsynaptic pyramidal neurons. Reduced levels of RELN expression in the adult brain induce cognitive impairment and dendritic spine density deficits. RELN supplementation recovers these deficits suggesting a trophic action for RELN in synaptic plasticity. We and others have shown that altered RELN expression in schizophrenia (SZ) and bipolar (BP) disorder patients is difficult to reconcile with classical Mendelian genetic disorders and it is instead plausible to associate these disorders with altered epigenetic homeostasis. Support for the contribution of altered epigenetic mechanisms in the down-regulation of RELN expression in corticolimbic structures of psychotic patients includes the concomitant increase of DNA-methyltransferases and the increased levels of the methyl donor S-adenosylmethionine (SAM). It is hypothesized that these conditions lead to RELN promoter hypermethylation and a reduction in RELN protein amounts in psychotic patients. The decreased synthesis and release of RELN from GABAergic corticolimbic neurons could serve as a model to elucidate the epigenetic pathophysiological mechanisms acting at pyramidal neuron dendrites that regulate synaptic plasticity and cognition in psychotic and non-psychotic subjects.</p>
</abstract>
<kwd-group>
<kwd>RELN</kwd>
<kwd>synaptic plasticity</kwd>
<kwd>promoter methylation</kwd>
<kwd>schizophrenia</kwd>
<kwd>bipolar disorder</kwd>
<kwd>Dab1</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="105"></ref-count>
<page-count count="11"></page-count>
<word-count count="8357"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>REELIN (RELN) is an extracellular matrix (ECM) glycoprotein that controls neuronal cell migration and the lamination of the corticolimbic structures during embryonic development (D’Arcangelo et al., <xref ref-type="bibr" rid="B16">1995</xref>). RELN also plays a role in controlling dendritic spines, and synapse structure and function in adulthood (Costa et al., <xref ref-type="bibr" rid="B15">2001</xref>). Research in the last 20 years, has suggested that abnormal brain RELN expression is a feature that associates with major neuropsychiatric disorders including schizophrenia (SZ), bipolar (BP) disorder (Impagnatiello et al., <xref ref-type="bibr" rid="B44">1998</xref>; Fatemi et al., <xref ref-type="bibr" rid="B24">2000</xref>; Guidotti et al., <xref ref-type="bibr" rid="B34">2000</xref>), autism (Fatemi, <xref ref-type="bibr" rid="B23">2002</xref>), depression (Lussier et al., <xref ref-type="bibr" rid="B57">2009</xref>, <xref ref-type="bibr" rid="B59">2011</xref>, <xref ref-type="bibr" rid="B58">2013</xref>), and Alzheimer’s disease (Herz and Chen, <xref ref-type="bibr" rid="B37">2006</xref>). While the role of RELN in dendritic spine structure, synapse plasticity, and cognitive function in adulthood has been extensively studied, considerably less research has focused on the mechanisms whereby RELN expression is altered in neuropsychiatric conditions. Here, we review evidence for a role of the epigenetic control of the expression of RELN in the regulation of neuronal plasticity and behavior in SZ and BP disorder patients compared with controls devoid of major psychiatric disorders.</p>
</sec>
<sec id="s2">
<title>RELN in the Adult Mammalian Brain</title>
<sec id="s2-1">
<title>Neuronal Location</title>
<p>In the cortex and hippocampus of adult rodents and primates, RELN is predominantly synthesized and secreted by GABAergic interneurons (Alcántara et al., <xref ref-type="bibr" rid="B3">1998</xref>; Impagnatiello et al., <xref ref-type="bibr" rid="B44">1998</xref>; Pesold et al., <xref ref-type="bibr" rid="B71">1998</xref>, <xref ref-type="bibr" rid="B72">1999</xref>; Guidotti et al., <xref ref-type="bibr" rid="B34">2000</xref>; Rodriguez et al., <xref ref-type="bibr" rid="B78">2000</xref>; Kadriu et al., <xref ref-type="bibr" rid="B46">2012</xref>). Immunohistochemistry coupled to <italic>in situ</italic> hybridization studies distinguishes at least two sets of GABAergic interneurons based on their ability to synthesize and secrete RELN. The first synthesizes and secretes RELN onto apical and basal dendrites of pyramidal neurons and includes GABAergic horizontal, double bouquet, multipolar and Martinotti neurons in layers 1 and 2 of the mammalian cortices (Figure <xref ref-type="fig" rid="F1">1</xref>). The second set of GABAergic neurons, which do not usually express RELN, include chandelier and basket interneurons that innervate the axon initial segment or somata of pyramidal neurons, respectively (Pesold et al., <xref ref-type="bibr" rid="B71">1998</xref>, <xref ref-type="bibr" rid="B72">1999</xref>). In contrast, in cerebellum, RELN is predominately synthesized by glutamatergic granule neurons, and is secreted by their parallel fiber axon terminals into the ECM surrounding the dendrites of GABAergic Purkinje cells (Pesold et al., <xref ref-type="bibr" rid="B71">1998</xref>). Studies in primary cultures of rat cerebellar granule cells suggest that RELN is secreted in the extracellular medium in a manner that is blocked by the constitutive secretory pathway inhibitor brefeldin. Moreover, secretion of RELN is independent of neuronal activity (Lacor et al., <xref ref-type="bibr" rid="B52">2000</xref>). These findings suggest the possibility that secretory pathway activators might be useful in facilitating RELN secretion when RELN expression is compromised.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Photomicrographs of 20 μm sections of prefrontal cortex (PFC) of a non-psychiatric subject (NPS) and of a schizophrenia patient (SZP) immunolabeled for RELN (A,C, left side) or Nissl-stained (B,D, right side).</bold> RELN positive neurons are mostly localized in layer 1. Note that the NPS has a higher density of RELN-positive cells and also a stronger extracellular diffuse RELN immunostaining halo. Reprinted with permission from Guidotti et al. (<xref ref-type="bibr" rid="B34">2000</xref>).</p>
</caption>
<graphic xlink:href="fncel-10-00089-g0001"></graphic>
</fig>
</sec>
<sec id="s2-2">
<title>Extracellular Location</title>
<p>Once released in the extracellular space, RELN binds to VLDL, APOE and α3β1 integrin receptors activating the signal transduction system in the effector cells including apical and basilar dendrites of pyramidal neurons in the neocortex or Purkinje cells in the cerebellum (D’Arcangelo et al., <xref ref-type="bibr" rid="B17">1999</xref>; Hiesberger et al., <xref ref-type="bibr" rid="B38">1999</xref>; Dong et al., <xref ref-type="bibr" rid="B20">2003</xref>; Strasser et al., <xref ref-type="bibr" rid="B86">2004</xref>).</p>
<p>Using electron microscopic techniques, Costa et al. (<xref ref-type="bibr" rid="B15">2001</xref>) demonstrated the presence of RELN-like immunoreactivity decorating the dendritic shafts and spines of distal apical dendrites of pyramidal neurons in the frontal cortex. This area, as well as the hippocampal fissure, is characterized by strong diffuse RELN–immunoreactivity (Pesold et al., <xref ref-type="bibr" rid="B71">1998</xref>). The colocalization of RELN with the α3 subunit of the integrin receptor at post-synaptic densities of adult rat and primate brains suggests that a RELN signaling mechanism involving integrin and VLDL and APOE2 receptors may be operative in modulating the strength of synaptic function (Rodriguez et al., <xref ref-type="bibr" rid="B78">2000</xref>; Dong et al., <xref ref-type="bibr" rid="B20">2003</xref>; Niu et al., <xref ref-type="bibr" rid="B66">2004</xref>). It has been shown that RELN interacting with VLDL, APOE2, or integrin receptors results in activation of the Src-tyrosine kinase family Fyn-kinase, leading to tyrosine phosphorylation and recruitment of the cytoplasmic adaptor protein DAB1 (Figure <xref ref-type="fig" rid="F2">2</xref>; Jossin et al., <xref ref-type="bibr" rid="B45">2003</xref>; Bock et al., <xref ref-type="bibr" rid="B8">2004</xref>; Kuo et al., <xref ref-type="bibr" rid="B51">2005</xref>). Studies suggest that DAB1 phosphorylation is a crucial step in the activation of RELN signal transduction pathways (Rice et al., <xref ref-type="bibr" rid="B77">1998</xref>; Trommsdorff et al., <xref ref-type="bibr" rid="B93">1999</xref>; Niu et al., <xref ref-type="bibr" rid="B66">2004</xref>; Howell and Pillai, <xref ref-type="bibr" rid="B41">2015</xref>). DAB1 is frequently expressed in proximity of synapses located on dendritic spines or shafts of cortical pyramidal neurons (Rodriguez et al., <xref ref-type="bibr" rid="B78">2000</xref>). Hence, phosphorylated DAB1 may regulate cytoskeletal protein synthesis at dendrites by activating the translation of dendritic resident mRNAs (see Figure <xref ref-type="fig" rid="F2">2</xref>, from Costa et al., <xref ref-type="bibr" rid="B15">2001</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Schematic representation of the RELN signaling pathways in dendritic spines.</bold> RELN released in the extracellular matrix (ECM) from the terminal of cortical GABAergic neuron binds to dendritic shafts and spines and modulates the transcriptional function of activated dendritic synapses. Modified from Costa et al. (<xref ref-type="bibr" rid="B15">2001</xref>). RELN binding to Integrin receptors located on dendritic spines mediates activation of focal adhesion kinase (FAK) that directly or indirectly, via activation of Fyn kinase, phosphorylates DAB1 adaptor protein resident in dendrites. Phosphorylated dendritic DAB1 may recruit or activate ribosomal structures and induce the synthesis of ARC (Activity regulated cytoskeletal-associated protein) or cytoskeletal proteins like β-actin.</p>
</caption>
<graphic xlink:href="fncel-10-00089-g0002"></graphic>
</fig>
</sec>
</sec>
<sec id="s3">
<title>RELN Regulates Spine Density and Excitatory Synaptic Function</title>
<p>Animal models in which RELN expression is genetically reduced provide important information on the impact of RELN on synaptic plasticity and cognition. <italic>Reeler</italic> mice display altered LTP and deficits in active avoidance tasks (Goldowitz and Koch, <xref ref-type="bibr" rid="B28">1986</xref>; Marrone et al., <xref ref-type="bibr" rid="B61">2006</xref>). Young adult heterozygous <italic>reeler</italic> mice (HRM) which exhibit a 50% reduction in RELN content have significantly reduced dendritic spine densities and also show a deficit in LTP (Tueting et al., <xref ref-type="bibr" rid="B94">1999</xref>, <xref ref-type="bibr" rid="B96">2006</xref>; Liu et al., <xref ref-type="bibr" rid="B56">2001</xref>; Levenson et al., <xref ref-type="bibr" rid="B53">2008</xref>; Niu et al., <xref ref-type="bibr" rid="B67">2008</xref>; Iafrati et al., <xref ref-type="bibr" rid="B43">2014</xref>). Adult HRM also have a defective molecular composition of the synaptic structure (Ventruti et al., <xref ref-type="bibr" rid="B99">2011</xref>), as well as deficits in excitatory postsynaptic responses to glutamate receptor agonists and reduced LTP (Levenson et al., <xref ref-type="bibr" rid="B54">2006</xref>). Addition of recombinant RELN to hippocampal slices or direct injection of RELN into the cerebral ventricles enhances hippocampal LTP (Beffert et al., <xref ref-type="bibr" rid="B5">2006</xref>; Pujadas et al., <xref ref-type="bibr" rid="B74">2010</xref>; Rogers et al., <xref ref-type="bibr" rid="B79">2011</xref>).</p>
<p>HRM also display deficits in cognitive function (Krueger et al., <xref ref-type="bibr" rid="B48">2006</xref>; Stranahan et al., <xref ref-type="bibr" rid="B85">2011</xref>), executive function (Brigman et al., <xref ref-type="bibr" rid="B9">2006</xref>), fear conditioning learning (Ammassari-Teule et al., <xref ref-type="bibr" rid="B4">2009</xref>), anxiety and motor impulsivity (Ognibene et al., <xref ref-type="bibr" rid="B69">2007</xref>). Importantly, RELN supplementation recovers sensory motor gating, synaptic plasticity, and associative learning deficits in HRM (Rogers et al., <xref ref-type="bibr" rid="B80">2013</xref>). In addition to the HRM data described above, Lussier et al. (<xref ref-type="bibr" rid="B58">2013</xref>) reported that hippocampal RELN deficiency elicited by chronic stress (repeated corticosterone treatment) can impair adult hippocampal neurogenesis and lead to the development of a depression-like phenotype. Co-treatment with antidepressant drugs prevents both RELN deficit and the development of the depression-like phenotype (Fenton et al., <xref ref-type="bibr" rid="B25">2015</xref>).</p>
<p>Addition of recombinant RELN to cortical synaptosomes <italic>in vitro</italic> induces the expression of activity-regulated cytoskeleton-associated protein (Arc; Dong et al., <xref ref-type="bibr" rid="B20">2003</xref>), and augments the density and clustering of proteins in postsynaptic membranes (i.e., neurotransmitter receptors), which provides further evidence of a functional role for RELN in regulating the synaptic strength of glutamatergic inputs onto dendritic spines (Caruncho et al., <xref ref-type="bibr" rid="B10">2004</xref>).</p>
</sec>
<sec id="s4">
<title>RELN in the Brains of Schizophrenia (SZ) and Bipolar (BP) Disorder Patients</title>
<p>A number of molecular, anatomical (dendritic spine density), behavioral, and cognitive deficits associated with reduced RELN expression (mRNA and protein) are observed in subjects with SZ and BP disorder. In different post-mortem brain cohorts, we and others have demonstrated that RELN expression is reduced by approximately 50% in the prefrontal cortex (PFC), temporal cortex, hippocampus, and caudate nucleus of patients with SZ and BP disorder (Impagnatiello et al., <xref ref-type="bibr" rid="B44">1998</xref>; Fatemi et al., <xref ref-type="bibr" rid="B24">2000</xref>; Guidotti et al., <xref ref-type="bibr" rid="B34">2000</xref>). In successive studies we found that the expression of RELN was paralleled by decreases in the levels of GAD67 but not DAB1 or GAD65. Slices from the same samples immunostained for RELN and counterstained for Nissl or NeuN to recognize neurons showed that RELN-positive neurons were significantly decreased by 30–50% in patients with SZ or BP disorder with psychosis but not in those with unipolar depression when compared to non-psychiatric subject (NPSs; Figure <xref ref-type="fig" rid="F1">1</xref>). Differences were absent for GAD65, and NeuN expression implying that RELN and GAD67 down-regulation is unrelated to neuronal damage (Guidotti et al., <xref ref-type="bibr" rid="B34">2000</xref>). The RELN and GAD67 downregulation is also unrelated to postmortem interval, dose, duration, or presence of antipsychotic medication. Similar to HRM, RELN deficiency in the neocortex of SZ and BP disorder patients is associated with a decrease in GAD67, reduced prepulse inhibition to startle, and loss of dendritic spines, all features associated with SZ pathology (Tueting et al., <xref ref-type="bibr" rid="B94">1999</xref>; Glantz and Lewis, <xref ref-type="bibr" rid="B27">2001</xref>; Liu et al., <xref ref-type="bibr" rid="B56">2001</xref>; Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>).</p>
<p>Like the RELN deficiency in the cerebellar cortex of HRM, the RELN deficiency in cerebellar cortex of SZ and BP disorder patients is associated with a 20% decrease of GABAergic Purkinje neurons (Hadj-Sahraoui et al., <xref ref-type="bibr" rid="B36">1996</xref>; Maloku et al., <xref ref-type="bibr" rid="B60">2010</xref>). Collectively these data suggest that RELN plays a central role in inducing and maintaining the structure and function of GABAergic and glutamatergic neurons and their reciprocal interactions (Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>).</p>
<p>Since SZ and BP disorder have a neurodevelopmental origin (Folsom and Fatemi, <xref ref-type="bibr" rid="B26">2013</xref>) and RELN is a major player in brain development and maturation (D’Arcangelo et al., <xref ref-type="bibr" rid="B16">1995</xref>), an important question raised by these studies is whether the altered epigenetic (promoter hypermethylation) regulation of RELN in brains of SZ and BP patients is initiated early in embryonic or perinatal life or develops later in life as the consequence of the GABAergic neuropathology related to the development of SZ morbidity. To address this question, the extent of methylation of the RELN promoter was measured in offspring born from mice stressed during pregnancy. These offspring, at adulthood, display SZ-like behavioral endophenotypes (increased locomotor activity, PPI, social recognition deficits), and a decrease of RELN, GAD67, and BDNF expression associated with an increase in methylation at their respective promoters. We also found that the amount of Methyl CpG Binding Protein 2 (MECP2) binding to the <italic>RELN</italic> promoter at birth was higher than that observed in the adult (Matrisciano et al., <xref ref-type="bibr" rid="B63">2013</xref>). These data suggest that RELN promoter hypermethylation is likely initiated early in life, including during embryonic life, and is then maintained throughout adulthood.</p>
</sec>
<sec id="s5">
<title>Is an Altered Epigenetic Regulation of Gene Expression the Molecular Mechanism Mediating RELN Expression Down-Regulation in SZ and BP Disorder?</title>
<p>Mutations in the RELN gene are associated with a form of autosomal recessive lissencephaly with abnormal axonal connectivity, and cerebellar hypoplasia (Hong et al., <xref ref-type="bibr" rid="B39">2000</xref>). Human subjects with RELN gene mutations exhibit marked ventricular dilation, mental retardation, and epilepsy and a marked decrease in muscle tone that appears of neurogenic origin (Hourihane et al., <xref ref-type="bibr" rid="B40">1993</xref>). Heterozygous RELN mutations have been shown to cause autosomal-dominant lateral temporal epilepsy (Dazzo et al., <xref ref-type="bibr" rid="B18">2015</xref>).</p>
<p>A highly conserved single nucleotide polymorphism (SNP) has been identified in the vicinity of the regulatory region of the RELN gene (Shifman et al., <xref ref-type="bibr" rid="B84">2008</xref>; Wedenoja et al., <xref ref-type="bibr" rid="B103">2010</xref>). This polymorphism is associated with an increased risk of psychotic symptoms. Although these studies highlight the importance of RELN gene variants as risk factors in the etiopathogenesis of psychiatric disorders, it is important to note that variants in the RELN gene are rare and cannot explain the high frequency of RELN expression downregulation observed in the general population of SZ, BP disorder and autism spectrum disorder patients (Zhang et al., <xref ref-type="bibr" rid="B105">2002</xref>; Lintas and Persico, <xref ref-type="bibr" rid="B55">2010</xref>; Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>; Wang et al., <xref ref-type="bibr" rid="B100">2014</xref>; Zhubi et al., <xref ref-type="bibr" rid="B106">2014</xref>).</p>
<p>The epidemiological and clinical evidence that SZ and BP disorders do not follow the rules expected for a Mendelian-genetic disorder led to the proposal that environmental insults may influence RELN gene expression by altering epigenetic regulatory mechanisms and led to the hypothesis that epigenetic factors are operative in mediating changes in the expression of RELN and other SZ candidate genes in psychotic patients (Costa et al., <xref ref-type="bibr" rid="B14">2003</xref>). To better understand the rules governing the epigenetic regulation of <italic>RELN</italic>, we cloned the human gene and experimentally examined its regulation in both neuroprogenitor NT2 cells (Chen et al., <xref ref-type="bibr" rid="B12">2002</xref>; Mitchell et al., <xref ref-type="bibr" rid="B65">2005</xref>) and mouse cortical neurons <italic>in vitro</italic> (Dong et al., <xref ref-type="bibr" rid="B20">2003</xref>; Noh et al., <xref ref-type="bibr" rid="B68">2005</xref>). Data from these studies support the concept that the <italic>RELN</italic> promoter is regulated epigenetically through changes in DNA methylation. Furthermore, we have reported that the down-regulation of RELN expression in GABAergic neurons of SZ and BP patients is associated with an overexpression of DNA methyltransferase 1 (DNMT1) and DNA methyltransferase 3a (DNMT3a) in neocortical and striatal GABAergic neurons (Veldic et al., <xref ref-type="bibr" rid="B97">2004</xref>, <xref ref-type="bibr" rid="B98">2007</xref>; Ruzicka et al., <xref ref-type="bibr" rid="B81">2007</xref>). DNMTs are a family of enzymes that catalyze the transfer of a methyl group from the methyl donor S-adenosylmethionine (SAM) to the 5′ carbon of cytosine of many gene promoters (Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>). Increased promoter methylation generally leads to decreased gene expression. Interestingly, the inhibitory action of DNMTs on RELN expression also likely occur through the formation of chromatin repressor complexes which include, in addition of DNMTs, also the methyl CpG binding domain proteins, SIN3A, and histone deacetylases (see Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref> for review).</p>
<p>The hypothesis that an epigenetic pathology of the <italic>Reln</italic> promoter is operative in the transcriptional down-regulation of the corresponding gene in SZ or BP disorder patients is supported by the evidence that there is an increased level of SAM in the PFC of these patients (Guidotti et al., <xref ref-type="bibr" rid="B35">2007</xref>), and that hypermethylation of the <italic>RELN</italic> promoter (Abdolmaleky et al., <xref ref-type="bibr" rid="B1">2005</xref>; Grayson et al., <xref ref-type="bibr" rid="B33">2005</xref>, <xref ref-type="bibr" rid="B29">2006</xref>; Lintas and Persico, <xref ref-type="bibr" rid="B55">2010</xref>) is associated with the down-regulation of the corresponding protein in the PFC of psychotic patients (Guidotti et al., <xref ref-type="bibr" rid="B34">2000</xref>), although negative findings for RELN promoter hypermethylation have also been reported (Mill et al., <xref ref-type="bibr" rid="B64">2008</xref>).</p>
<p>In other studies a decreased histone methylation at GABAergic gene promoters (Huang et al., <xref ref-type="bibr" rid="B42">2007</xref>), and an increased histone deacetylase -1 expression and down regulation of GABAergic gene expression in PFC and hippocampus of SZ patients have been reported (Benes et al., <xref ref-type="bibr" rid="B6">2007</xref>; Sharma et al., <xref ref-type="bibr" rid="B83">2008</xref>). A summary of many of the methylation studies of <italic>RELN</italic> in neuropsychiatric patients, SZ-like epigenetic mouse models, and neuronal culture systems are summarized in Table <xref ref-type="table" rid="T1">1</xref>. These data are consistent with the epigenetic GABAergic theory of major psychosis (Costa et al., <xref ref-type="bibr" rid="B14">2003</xref>; Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>) and suggest that<italic> RELN</italic> promoter methylation should be further studied to establish its temporal and casual association with the etiopathogenesis of SZ and BP disorder.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>Summary showing studies of RELN methylation relevant to neurobiology<sup>a</sup></bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Reference</th>
<th align="center" colspan="1" rowspan="1">Location<sup>b</sup></th>
<th align="center" colspan="1" rowspan="1">Species</th>
<th align="center" colspan="1" rowspan="1">Tissue</th>
<th align="center" colspan="1" rowspan="1">Design</th>
<th align="center" colspan="1" rowspan="1">Method</th>
<th align="center" colspan="1" rowspan="1">Result</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Abdolmaleky et al. (<xref ref-type="bibr" rid="B1">2005</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −700 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Lobe</td>
<td align="left" colspan="1" rowspan="1" valign="top">RELN methylation in SZ vs. Con were compared</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq, Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> promoter is hypermethylated in SZ</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aberg et al. (<xref ref-type="bibr" rid="B2">2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">First Intron</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole Blood</td>
<td align="left" colspan="1" rowspan="1" valign="top">RELN methylation in SZ vs. Con were compared</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methyl Binding Domain- profiling</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> is hypermethylated in SZ</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Blaze et al. (<xref ref-type="bibr" rid="B7">2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">Medial Prefrontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comparison of methylation status at the <italic>Reln</italic> promoter as a function of post-natal maltreatment or nurturing care</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Reln</italic> methylation varies by condition, age and sex</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al. (<xref ref-type="bibr" rid="B12">2002</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −527 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NT2 Cells</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> methylation in differentiated vs. control neuroprogenitor cells <italic>in vitro</italic> were examined</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> hypermethylation in NT2 cells that is demethylated on differentiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dong et al. (<xref ref-type="bibr" rid="B21">2007</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −520 to −198 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methionine (MET) induced hypermethylation of the <italic>RELN</italic> promoter was examined and the effects of VPA and MS-275 on this methylation <italic>in vivo</italic> were evaluated</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">MET induces <italic>RELN</italic> methylation, while VPA and MS-275 reverse this methylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dong et al. (<xref ref-type="bibr" rid="B22">2016</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −220 to +70 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS mice were examined for changes in <italic>Reln</italic> promoter methylation or hydroymethylation at PND 75 following either vehicle (VEH), clozapine (CLZ) or haloperidol (HAL)</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeDIP, hMeDIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">At PND 75, PRS strongly induces RELN promoter hypermethylation and, to a lesser extent hydroxyl methylation, of the <italic>Reln</italic> promoter. CLZ, but not HAL, attenuates the PRS-induced hypermethylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Grayson et al. (<xref ref-type="bibr" rid="B33">2005</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −527 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">BA 9 and 10</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> methylation in SZ vs. Con were compared</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> is hypermethylated in SZ</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kobow et al. (<xref ref-type="bibr" rid="B47">2009</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −500 to +100 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human temporal lobe epilepsy (TLE) biopsy specimens vs. autopsied control tissue were compared</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> promoter hypermethylation was observed in TLE biopsies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kundakovic et al. (<xref ref-type="bibr" rid="B50">2009</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −250 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NT2 Cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">The effect of the HDAC inhibitor, MS-275, on RELN promoter methylation was determined</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeDIP followed by qPCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">MS-275 induces <italic>RELN</italic> promoter demethylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Levenson et al. (<xref ref-type="bibr" rid="B54">2006</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: between −1000 and −500 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampal Slice Preparation</td>
<td align="left" colspan="1" rowspan="1" valign="top">The response of neurons in slices to the effects of Protein Kinase C (PKC) activation by phorbol esters and or by inhibitors of DNA methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reln promoter methylation is decreased by inhibitors of DNA methylation and activators of PKC</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lintas and Persico (<xref ref-type="bibr" rid="B55">2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −413 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">BA 41 and 42</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> promoter methylation was examined in pre- and post-pubertal post-mortem brain from non-psychiatric subjects</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top">Post-pubertal <italic>RELN</italic> promoter is hypermethylated compared with pre-pubertal <italic>RELN</italic></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Matrisciano et al. (<xref ref-type="bibr" rid="B62">2011</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −423 to −252 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS mice were examined for methylation vs. non-stressed mice and the effect of LY379268 on this methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeDIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS mice showed <italic>Reln</italic> promoter methylation which was reduced by LY379268</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Matrisciano et al. (<xref ref-type="bibr" rid="B63">2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −432 to −252 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS mice were analyzed for changes in Reln promoter methylation and hydroxymethylation vs. Con</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeDIP and hMeDIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS mice showed elevated Reln promoter methylation and hydroxymethylation at PND 60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mill et al. (<xref ref-type="bibr" rid="B64">2008</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>RELN</italic> methylation in SZ vs. BD vs. Con were compared</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pyrosequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">No change between groups</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mitchell et al. (<xref ref-type="bibr" rid="B65">2005</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: below −500 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NT2 Cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Determined the effects of HDAC and DNMT inhibitors on <italic>RELN</italic> promoter methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top">TSA, VPA and AZA induces <italic>RELN</italic> hypomethylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Noh et al. (<xref ref-type="bibr" rid="B68">2005</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −340 to +140 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical Neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">MET was used to manipulate <italic>RELN</italic> promoter methylation <italic>in vitro</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top">MET induced <italic>RELN</italic> promoter hypermethylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Palacios-Garcia et al. (<xref ref-type="bibr" rid="B70">2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −786 to −625 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">Whole Cortex Cultured Neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">PRS rats were analyzed for changes in <italic>Reln</italic> promoter methylation <italic>in vivo</italic> and <italic>in vitro</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation sensitive restriction enzyme PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Reln</italic> promoter methylation is increased in newborn PRS rats and in cultured neurons <italic>in vitro</italic></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Qin et al. (<xref ref-type="bibr" rid="B75">2011</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">The effects of maternal deprivation on <italic>Reln</italic> promoter methylation were examined</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal deprivation facilitated increased <italic>Reln</italic> promoter methylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sui and Li (<xref ref-type="bibr" rid="B87">2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −700 to −400 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter methylation was analyzed in rats with perinatal hypothyroidism at PND 1 through 60</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypothyroid rats show elevated <italic>Reln</italic> promoter methylation at PND 1, 5 and 15 relative to Con</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sui et al. (<xref ref-type="bibr" rid="B88">2012</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rat</td>
<td align="left" colspan="1" rowspan="1" valign="top">Medial Prefrontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter methylation was analyzed following the induction of LTP as compared with Con</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methylation specific PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">High frequency stimulations induce DNA demethylation at the <italic>Reln</italic> promoter vs. Con</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tremolizzo et al. (<xref ref-type="bibr" rid="B91">2002</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −340 to +160 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frontal Cortex</td>
<td align="left" colspan="1" rowspan="1" valign="top">The effects of VPA treatment on the MET-induced hypermethylation of the <italic>RELN</italic> promoter were evaluated</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bisulfite seq</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methionine induces <italic>RELN</italic> methylation, while VPA reverses this effect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zhubi et al. (<xref ref-type="bibr" rid="B106">2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter: −220 to +70 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cerebellum</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reln promoter methylation and hydroxymethylation were analyzed in autism spectrum disorder (ASD) vs. typically developed subjects (Con)</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeDIP and hMeDIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">While <italic>RELN</italic> promoter methylation levels are unchanged between ASD and Con, 5hmC content at the promoter is increased</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic><sup>a</sup>The above studies do not include at least one report (Tochigi et al., <xref ref-type="bibr" rid="B90">2008</xref>) that showed no detectable RELN promoter methylation in either SZ or control subjects by pyrosequencing. In addition, there are numerous studies showing that elevated RELN promoter methylation is associated with poor prognosis in various types of cancers. We apologize for any relevant studies that were inadvertently omitted from this list. <sup>b</sup>For precise locations of the RELN methylation see the associated reference. The locations provided are approximate and if no coordinates are indicated, then the information was not in the original report. For example, Promoter (without additional information) indicates that the authors specified the RELN promoter without giving additional coordinates. ASD, Autism spectrum disorder; Bisulfite seq, Bisulfite sequencing; CLZ, Clozapine; Con, Control; HAL, Haloperidol; hMeDIP, Hydroxymethyl DNA immunoprecipitation; LTP, Long-term potentiation; MeDIP, Methyl DNA immunoprecipitation; NT2 cells, Ntera2 cells; PCR, Polymerase chain reaction; PKC, Protein kinase C; PND, Post-natal day; PRS, Pre-natal restraint stress; TLE, Temporal lobe epilepsy; VEH, Vehicle; VPA, Valproic acid</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s6">
<title>RELN, Spine Density Down Regulation and Cognitive Performance Deficits Induced by L-Methionine Treatment</title>
<p>Support for the hypothesis that an increase of DNA methylation contributes to the down-regulation of RELN and other GABAergic or glutamatergic genes in psychotic patients is sustained by clinical studies conducted in the early 1970s (for review see Wyatt et al., <xref ref-type="bibr" rid="B104">1971</xref>; Cohen et al., <xref ref-type="bibr" rid="B13">1974</xref>; Grayson et al., <xref ref-type="bibr" rid="B30">2009</xref>). In these studies L-methionine (MET, the precursor of SAM), administered in large doses (10–20 g/day) for 3–4 weeks to SZ patients was reported to exacerbate psychotic symptomatology (Cohen et al., <xref ref-type="bibr" rid="B13">1974</xref>; Grayson et al., <xref ref-type="bibr" rid="B30">2009</xref>). Patients were administered large doses of L-methionine either with or without a monoamine oxidase inhibitor in an attempt to reduce the levels of putative bioactive psychedelic compounds. Interestingly, many of the treated patients responded with a worsening of their symptoms (Cohen et al., <xref ref-type="bibr" rid="B13">1974</xref>).</p>
<p>In both mouse FC and neuronal cultures, the administration of large doses of L-methionine increases SAM levels and facilitates the hypermethylation of GABAergic gene promoters, including <italic>Reln</italic>, and <italic>GAD67</italic> and the reduced expression of these genes (Tremolizzo et al., <xref ref-type="bibr" rid="B91">2002</xref>, <xref ref-type="bibr" rid="B92">2005</xref>; Mitchell et al., <xref ref-type="bibr" rid="B65">2005</xref>; Noh et al., <xref ref-type="bibr" rid="B68">2005</xref>; Chen et al., <xref ref-type="bibr" rid="B11">2007</xref>). Similar to the HRM, spine density is also decreased in the dendrites of mice treated with L-methionine (Figure <xref ref-type="fig" rid="F3">3</xref>, Tueting et al., <xref ref-type="bibr" rid="B95">2010</xref>). Furthermore, L-methionine treated mice display SZ-like behavioral abnormalities (Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>). Collectively, these data suggest that the reduction of dendritic spines observed in brain of L-methionine-treated mice are likely due to MET-induced altered epigenetic mechanisms that lead to decreased expression of RELN (Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>; Tueting et al., <xref ref-type="bibr" rid="B95">2010</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold>Photomicrographs of Golgi stained layer III pyramidal neurons in vehicle (VEH) and methionine (MET) treated mouse frontal cortex.</bold> Top panel: 10× objective; Middle panel: 20×; Bottom panel: 100× Vehicle or L-methionine (5.2 mmol/kg/twice a day) was administered for 14 days. Reprinted with permission from Tueting et al. (<xref ref-type="bibr" rid="B95">2010</xref>).</p>
</caption>
<graphic xlink:href="fncel-10-00089-g0003"></graphic>
</fig>
</sec>
<sec id="s7">
<title>RELN Promoter Methylation in Neurons is a Dynamic Process that can be Targeted by Environmental Factors and Drugs</title>
<p>The dogma that in post-mitotic neurons DNA methylation patterns are established during development and remain stable thereafter (Razin and Shemer, <xref ref-type="bibr" rid="B76">1995</xref>) has been challenged by convincing evidence that in post-mitotic neurons, methylation patterns of specific cytosine/guanine (CpG) dinucleotide-rich promoters, change rapidly. Thus, in neurons, promoter methylation provides a series of targets on which the environment, drugs, and/or toxins can modify transcription and affect neuronal phenotype profiles without altering the genotype (Szyf, <xref ref-type="bibr" rid="B89">2009</xref>). To verify this hypothesis, we treated (Tremolizzo et al., <xref ref-type="bibr" rid="B91">2002</xref>, <xref ref-type="bibr" rid="B92">2005</xref>; Tueting et al., <xref ref-type="bibr" rid="B95">2010</xref>) mice protractedly with L-methionine (as described above) and measured the ratio of 5 methyl cytosine (5mC) to unmethylated cytosine (C) of the murine RELN CpG-enriched promoter region from −340 to +160 bp (Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>) or the murine GAD<sub>67</sub> CpG-enriched promoter region from −760 to −311 bp (Satta et al., <xref ref-type="bibr" rid="B82">2008</xref>) by measuring the fraction of promoters immunoprecipitated by specific anti-5mC or anti-MeCP2 antibodies with competitive RT-PCR and internal standards (Dong et al., <xref ref-type="bibr" rid="B19">2005</xref>). We found that (Dong et al., <xref ref-type="bibr" rid="B19">2005</xref>; Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>) methionine induces an increase of brain RELN and GAD<sub>67</sub> promoter methylation (Dong et al., <xref ref-type="bibr" rid="B19">2005</xref>), and downregulation of RELN and GAD<sub>67</sub> mRNA and cognate protein expression associated with decreased spine density (Figure <xref ref-type="fig" rid="F3">3</xref>), and SZ-like behavioral modifications (Tremolizzo et al., <xref ref-type="bibr" rid="B91">2002</xref>, <xref ref-type="bibr" rid="B92">2005</xref>; Tueting et al., <xref ref-type="bibr" rid="B95">2010</xref>). The effects of methionine on the RELN promoter, RELN protein level, dendritic spine density, and SZ-like behavioral modifications are reversed by the administration of Valproic acid (VPA) and other HDAC inhibitors (Dong et al., <xref ref-type="bibr" rid="B19">2005</xref>; Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>). These findings, together with data obtained in the HRM, suggest the working hypothesis that the down-regulation of spine density and SZ-like behavioral modifications in L-methionine treated mice may be, in part, due to decreased expression of RELN.</p>
</sec>
<sec id="s8">
<title>Concluding Remarks</title>
<p>SZ and BP are neurodevelopmental disorders with genetic risk load and behavioral and neurochemical SZ-like phenotypes triggered by exposure to prenatal or perinatal environmental insults: stress, toxins, infection, trauma. In mice exposed prenatally to restraint stress, we found increased DNMT levels that are associated with RELN promoter hypermethylation, RELN expression downregulation, SZ-like epigenetic behavioral modifications, and decreased dendritic spine density in adultood (Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>; Tueting et al., <xref ref-type="bibr" rid="B95">2010</xref>; Dong et al., <xref ref-type="bibr" rid="B22">2016</xref>). L-Methionine supplementation in rats induces epigenetic variations including RELN promoter hypermethylation in offspring (Weaver et al., <xref ref-type="bibr" rid="B102">2005</xref>). Further, there is an epigenomic reprogramming of RELN and glucocorticoid receptors in hippocampal pyramidal neurons after methionine administration (Weaver et al., <xref ref-type="bibr" rid="B101">2006</xref>). Our studies in cultured mouse cortical neurons (Noh et al., <xref ref-type="bibr" rid="B68">2005</xref>) and human neuronal progenitors (Kundakovic et al., <xref ref-type="bibr" rid="B49">2007</xref>, <xref ref-type="bibr" rid="B50">2009</xref>) not only show that the hypermethylation of promoters induced by L-methionine is blocked by siRNA-mediated DNMT-KO or by reduction of DNMT activity with small molecule antagonists but also that this blockade induces the overexpression of RELN, GAD<sub>67</sub>, or BDNF proteins (Kundakovic et al., <xref ref-type="bibr" rid="B49">2007</xref>, <xref ref-type="bibr" rid="B50">2009</xref>).</p>
<p>Collectively, these data challenge the classic concept that 5-methylcytosine patterns in DNA remain stable in post-mitotic neurons and strongly suggest that by increasing brain SAM content, L-methionine facilitates the promoter methylation mediated by DNMT1 or DNMT3a in the central nervous system (Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>). Unlike the DNA sequence of a cell, which is stable and strongly conserved, epigenetic processes that impact DNA methylation and chromatin architecture are highly dynamic. That is, they can be tissue-specific, developmentally-regulated, and modified by a wide range of drugs and other environmental factors (Szyf, <xref ref-type="bibr" rid="B89">2009</xref>; Ptak and Petronis, <xref ref-type="bibr" rid="B73">2010</xref>; Grayson and Guidotti, <xref ref-type="bibr" rid="B31">2013</xref>; Dong et al., <xref ref-type="bibr" rid="B22">2016</xref>).</p>
<p>Studies using the L-methionine mouse model or offspring of restraint stressed mothers may be aimed at determining whether antipsychotics capable of reducing RELN promoter methylation (e.g., clozapine), enhance spine density, and relieve SZ-like epigenetic behaviors (Tremolizzo et al., <xref ref-type="bibr" rid="B92">2005</xref>; Dong et al., <xref ref-type="bibr" rid="B22">2016</xref>). These models should provide useful preclinical tools for screening small molecules for their capacity to reverse SZ candidate gene promoter methylation and the associated neuronal and behavioral deficits.</p>
</sec>
<sec id="s9">
<title>Author Contributions</title>
<p>All authors contributed equally to the ideas and editing of the manuscript.</p>
</sec>
<sec id="s10">
<title>Funding</title>
<p>AG is supported by the following NIH grants AA022538, R01 MH093348, R01 MH101043, DRG is supported by AA022538. HJC is supported by a SHRF Establishment Grant, and a NSERC Discovery grant.</p>
</sec>
<sec id="s11">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdolmaleky</surname><given-names>H. M.</given-names></name><name><surname>Cheng</surname><given-names>K. H.</given-names></name><name><surname>Russo</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>Faraone</surname><given-names>S. V.</given-names></name><name><surname>Wilcox</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Hypermethylation of the reelin (Reelin) promoter in the brain of schizophrenic patients: a preliminary report</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>134B</volume>, <fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30140</pub-id><pub-id pub-id-type="pmid">15717292</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aberg</surname><given-names>K. A.</given-names></name><name><surname>McClay</surname><given-names>J. L.</given-names></name><name><surname>Nerella</surname><given-names>S.</given-names></name><name><surname>Clark</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults</article-title>. <source/>JAMA Psychiatry
<volume>71</volume>, <fpage>255</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.3730</pub-id><pub-id pub-id-type="pmid">24402055</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcántara</surname><given-names>S.</given-names></name><name><surname>Ruiz</surname><given-names>M.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name><name><surname>Ezan</surname><given-names>F.</given-names></name><name><surname>de Lecea</surname><given-names>L.</given-names></name><name><surname>Curran</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>7779</fpage>–<lpage>7799</lpage>. <pub-id pub-id-type="pmid">9742148</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammassari-Teule</surname><given-names>M.</given-names></name><name><surname>Sgobio</surname><given-names>C.</given-names></name><name><surname>Biamonte</surname><given-names>F.</given-names></name><name><surname>Marrone</surname><given-names>C.</given-names></name><name><surname>Mercuri</surname><given-names>N. B.</given-names></name><name><surname>Keller</surname><given-names>F.</given-names></name></person-group> (<year>2009</year>). <article-title>Reelin haploinsufficiency reduces the density of PV<sup>+</sup> neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors</article-title>. <source/>Psychopharmacology (Berl)
<volume>204</volume>, <fpage>511</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-009-1483-x</pub-id><pub-id pub-id-type="pmid">19277610</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beffert</surname><given-names>U.</given-names></name><name><surname>Durudas</surname><given-names>A.</given-names></name><name><surname>Weeber</surname><given-names>E. J.</given-names></name><name><surname>Stolt</surname><given-names>P. C.</given-names></name><name><surname>Giehl</surname><given-names>K. M.</given-names></name><name><surname>Sweatt</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>2041</fpage>–<lpage>2052</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4566-05.2006</pub-id><pub-id pub-id-type="pmid">16481437</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benes</surname><given-names>F. M.</given-names></name><name><surname>Lim</surname><given-names>B.</given-names></name><name><surname>Matzilevich</surname><given-names>D.</given-names></name><name><surname>Walsh</surname><given-names>J. P.</given-names></name><name><surname>Subburaju</surname><given-names>S.</given-names></name><name><surname>Minns</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>104</volume>, <fpage>10164</fpage>–<lpage>10169</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0703806104</pub-id><pub-id pub-id-type="pmid">17553960</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaze</surname><given-names>J.</given-names></name><name><surname>Scheuing</surname><given-names>L.</given-names></name><name><surname>Roth</surname><given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential methylation of genes in the medial prefrontal cortex of developing and adult rats following exposure to maltreatment or nurturing care during infancy</article-title>. <source/>Dev. Neurosci.
<volume>35</volume>, <fpage>306</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1159/000350716</pub-id><pub-id pub-id-type="pmid">23751776</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>H. H.</given-names></name><name><surname>Jossin</surname><given-names>Y.</given-names></name><name><surname>May</surname><given-names>P.</given-names></name><name><surname>Bergner</surname><given-names>O.</given-names></name><name><surname>Herz</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>33471</fpage>–<lpage>33479</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m401770200</pub-id><pub-id pub-id-type="pmid">15175346</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigman</surname><given-names>J. L.</given-names></name><name><surname>Padukiewicz</surname><given-names>K. E.</given-names></name><name><surname>Sutherland</surname><given-names>M. L.</given-names></name><name><surname>Rothblat</surname><given-names>L. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Executive functions in the heterozygous reeler mouse model of schizophrenia</article-title>. <source/>Behav. Neurosci.
<volume>120</volume>, <fpage>984</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.120.4.984</pub-id><pub-id pub-id-type="pmid">16893304</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Dopeso-Reyes</surname><given-names>I. G.</given-names></name><name><surname>Loza</surname><given-names>M. I.</given-names></name><name><surname>Rodríguez</surname><given-names>M. A.</given-names></name></person-group> (<year>2004</year>). <article-title>A GABA, reelin and the neurodevelopmental hypothesis of schizophrenia</article-title>. <source/>Crit. Rev. Neurobiol.
<volume>16</volume>, <fpage>25</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevNeurobiol.v16.i12.20</pub-id><pub-id pub-id-type="pmid">15581396</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Agis-Balboa</surname><given-names>R. C.</given-names></name><name><surname>Pinna</surname><given-names>G.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Induction of the reelin promoter by retinoic acid is mediated by Sp1</article-title>. <source/>J. Neurochem.
<volume>103</volume>, <fpage>650</fpage>–<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04797.x</pub-id><pub-id pub-id-type="pmid">17666047</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sharma</surname><given-names>R. P.</given-names></name><name><surname>Costa</surname><given-names>R. H.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2002</year>). <article-title>On the epigenetic regulation of the human reelin promoter</article-title>. <source/>Nucleic Acids Res.
<volume>30</volume>, <fpage>2930</fpage>–<lpage>2939</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkf401</pub-id><pub-id pub-id-type="pmid">12087179</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S. M.</given-names></name><name><surname>Nichols</surname><given-names>A.</given-names></name><name><surname>Wyatt</surname><given-names>R.</given-names></name><name><surname>Pollin</surname><given-names>W.</given-names></name></person-group> (<year>1974</year>). <article-title>The administration of methionine to chronic schizophrenic patients: a review of ten studies</article-title>. <source/>Biol. Psychiatry
<volume>8</volume>, <fpage>209</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="pmid">4601948</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Noh</surname><given-names>J. S.</given-names></name><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>REELIN and schizophrenia: a disease at the interface of the genome and the epigenome</article-title>. <source/>Mol. Interv.
<volume>2</volume>, <fpage>47</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1124/mi.2.1.47</pub-id><pub-id pub-id-type="pmid">14993361</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Pappas</surname><given-names>G. D.</given-names></name><name><surname>Pesold</surname><given-names>C.</given-names></name></person-group> (<year>2001</year>). <article-title>Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability</article-title>. <source/>Neurobiol. Dis.
<volume>8</volume>, <fpage>723</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.2001.0436</pub-id><pub-id pub-id-type="pmid">11592844</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name><name><surname>Homayouni</surname><given-names>R.</given-names></name><name><surname>Keshvara</surname><given-names>L.</given-names></name><name><surname>Rice</surname><given-names>D. S.</given-names></name><name><surname>Sheldon</surname><given-names>M.</given-names></name><name><surname>Curran</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>Reelin is a ligand for lipoprotein receptors</article-title>. <source/>Neuron
<volume>24</volume>, <fpage>471</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80860-0</pub-id><pub-id pub-id-type="pmid">10571240</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name><name><surname>Miao</surname><given-names>G. G.</given-names></name><name><surname>Chen</surname><given-names>S. C.</given-names></name><name><surname>Soares</surname><given-names>H. D.</given-names></name><name><surname>Morgan</surname><given-names>J. I.</given-names></name><name><surname>Curran</surname><given-names>T.</given-names></name></person-group> (<year>1995</year>). <article-title>A protein related to extracellular matrix proteins deleted in the mouse mutant reeler</article-title>. <source/>Nature
<volume>374</volume>, <fpage>719</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1038/374719a0</pub-id><pub-id pub-id-type="pmid">7715726</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dazzo</surname><given-names>E.</given-names></name><name><surname>Fanciulli</surname><given-names>M.</given-names></name><name><surname>Serioli</surname><given-names>E.</given-names></name><name><surname>Minervini</surname><given-names>G.</given-names></name><name><surname>Pulitano</surname><given-names>P.</given-names></name><name><surname>Binelli</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy</article-title>. <source/>Am. J. Hum. Genet.
<volume>96</volume>, <fpage>992</fpage>–<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.04.020</pub-id><pub-id pub-id-type="pmid">26046367</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Agis-Balboa</surname><given-names>R. C.</given-names></name><name><surname>Simonini</surname><given-names>M. V.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine- induced mouse model of schizophrenia</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>12578</fpage>–<lpage>12583</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0505394102</pub-id><pub-id pub-id-type="pmid">16113080</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Caruncho</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>W. S.</given-names></name><name><surname>Smalheiser</surname><given-names>N. R.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>100</volume>, <fpage>5479</fpage>–<lpage>5484</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1031602100</pub-id><pub-id pub-id-type="pmid">12707415</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>104</volume>, <fpage>4676</fpage>–<lpage>4681</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0700529104</pub-id><pub-id pub-id-type="pmid">17360583</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Matrisciano</surname><given-names>F.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>:<fpage>e711</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2015.191</pub-id><pub-id pub-id-type="pmid">26756904</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name></person-group> (<year>2002</year>). <article-title>The role of Reelin in pathology of autism</article-title>. <source/>Mol. Psychiatry
<volume>7</volume>, <fpage>919</fpage>–<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001248</pub-id><pub-id pub-id-type="pmid">12399938</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Earle</surname><given-names>J. A.</given-names></name><name><surname>McMenomy</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Hippocampal CA4 Reelin-positive neurons</article-title>. <source/>Mol. Psychiatry
<volume>5</volume>:<fpage>571</fpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000794</pub-id><pub-id pub-id-type="pmid">11175329</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Fournier</surname><given-names>N. M.</given-names></name><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Romay-Tallon</surname><given-names>R.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression and neuronal maturation</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>60</volume>, <fpage>52</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.02.001</pub-id><pub-id pub-id-type="pmid">25681757</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folsom</surname><given-names>T. D.</given-names></name><name><surname>Fatemi</surname><given-names>S. H.</given-names></name></person-group> (<year>2013</year>). <article-title>The involvement of Reelin in neurodevelopmental disorders</article-title>. <source/>Neuropharmacology
<volume>68</volume>, <fpage>122</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.08.015</pub-id><pub-id pub-id-type="pmid">22981949</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glantz</surname><given-names>L. A.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Dendritic spine density in schizophrenia and depression</article-title>. <source/>Arch. Gen. Psychiatry
<volume>58</volume>:<fpage>203</fpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.58.2.203</pub-id><pub-id pub-id-type="pmid">11177126</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldowitz</surname><given-names>D.</given-names></name><name><surname>Koch</surname><given-names>J.</given-names></name></person-group> (<year>1986</year>). <article-title>Performance of normal and neurological mutant mice on radial arm maze and active avoidance tasks</article-title>. <source/>Behav. Neural Biol.
<volume>46</volume>, <fpage>216</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/s0163-1047(86)90696-5</pub-id><pub-id pub-id-type="pmid">3767833</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Kundakovic</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>The human reelin gene: transcription factors (+), repressors (−) and the methylation switch (+/−) in schizophrenia</article-title>. <source/>Pharmacol. Ther.
<volume>111</volume>, <fpage>272</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.01.007</pub-id><pub-id pub-id-type="pmid">16574235</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia</article-title>. <source/>Epigenetics
<volume>4</volume>, <fpage>144</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.4161/epi.4.3.8534</pub-id><pub-id pub-id-type="pmid">19395859</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>The dynamics of DNA methylation in schizophrenia and related psychiatric disorders</article-title>. <source/>Neuropsychopharmacology
<volume>38</volume>, <fpage>138</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2012.125</pub-id><pub-id pub-id-type="pmid">22948975</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sharma</surname><given-names>R. P.</given-names></name><name><surname>Mitchell</surname><given-names>C. P.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Reelin promoter hypermethylation in schizophrenia</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>9341</fpage>–<lpage>9346</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0503736102</pub-id><pub-id pub-id-type="pmid">15961543</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Auta</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Di-Giorgi-Gerevni</surname><given-names>V.</given-names></name><name><surname>Dwivedi</surname><given-names>Y.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study</article-title>. <source/>Arch. Gen. Psychiatry
<volume>57</volume>, <fpage>1061</fpage>–<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.11.1061</pub-id><pub-id pub-id-type="pmid">11074872</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Ruzicka</surname><given-names>W.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Pinna</surname><given-names>G.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis</article-title>. <source/>Neuroreport
<volume>18</volume>, <fpage>57</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1097/wnr.0b013e32800fefd7</pub-id><pub-id pub-id-type="pmid">17259861</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadj-Sahraoui</surname><given-names>N.</given-names></name><name><surname>Frédéric</surname><given-names>F.</given-names></name><name><surname>Delhaye-Bouchaud</surname><given-names>N.</given-names></name><name><surname>Mariani</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse</article-title>. <source/>J. Neurogenet.
<volume>11</volume>, <fpage>45</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.3109/01677069609107062</pub-id><pub-id pub-id-type="pmid">10876649</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herz</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Reelin, lipoprotein receptors and synaptic plasticity</article-title>. <source/>Nat. Rev. Neurosci.
<volume>7</volume>, <fpage>850</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2009</pub-id><pub-id pub-id-type="pmid">17053810</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiesberger</surname><given-names>T.</given-names></name><name><surname>Trommsdorff</surname><given-names>M.</given-names></name><name><surname>Howell</surname><given-names>B. W.</given-names></name><name><surname>Goffinet</surname><given-names>A.</given-names></name><name><surname>Mumby</surname><given-names>M. C.</given-names></name><name><surname>Cooper</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation</article-title>. <source/>Neuron
<volume>24</volume>, <fpage>481</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80861-2</pub-id><pub-id pub-id-type="pmid">10571241</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S. E.</given-names></name><name><surname>Shugart</surname><given-names>Y. Y.</given-names></name><name><surname>Huang</surname><given-names>D. T.</given-names></name><name><surname>Shahwan</surname><given-names>S. A.</given-names></name><name><surname>Grant</surname><given-names>P. E.</given-names></name><name><surname>Hourihane</surname><given-names>J. O.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human Reelin mutations</article-title>. <source/>Nat. Genet.
<volume>26</volume>, <fpage>93</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/79246</pub-id><pub-id pub-id-type="pmid">10973257</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hourihane</surname><given-names>J. O.</given-names></name><name><surname>Bennett</surname><given-names>C. P.</given-names></name><name><surname>Chaudhuri</surname><given-names>R.</given-names></name><name><surname>Robb</surname><given-names>S. A.</given-names></name><name><surname>Martin</surname><given-names>N. D.</given-names></name></person-group> (<year>1993</year>). <article-title>A sibship with a neuronal migration defect, cerebellar hypoplasia and congenital lymphedema</article-title>. <source/>Neuropediatrics
<volume>24</volume>, <fpage>43</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1055/s-2008-1071511</pub-id><pub-id pub-id-type="pmid">7682675</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>K. R.</given-names></name><name><surname>Pillai</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Long-term effects of prenatal hypoxia on schizophrenia-like phenotype in heterozygous reeler mice</article-title>. <source/>Mol. Neurobiol. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1007/s12035-015-9265-4</pub-id><pub-id pub-id-type="pmid">26059812</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H. S.</given-names></name><name><surname>Matevossian</surname><given-names>A.</given-names></name><name><surname>Whittle</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Schumacher</surname><given-names>A.</given-names></name><name><surname>Baker</surname><given-names>S. P.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>11254</fpage>–<lpage>11262</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3272-07.2007</pub-id><pub-id pub-id-type="pmid">17942719</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iafrati</surname><given-names>J.</given-names></name><name><surname>Orejarena</surname><given-names>M. J.</given-names></name><name><surname>Lassalle</surname><given-names>O.</given-names></name><name><surname>Bouamrane</surname><given-names>L.</given-names></name><name><surname>Gonzalez-Campo</surname><given-names>C.</given-names></name><name><surname>Chavis</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway</article-title>. <source/>Mol. Psychiatry
<volume>19</volume>, <fpage>417</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.66</pub-id><pub-id pub-id-type="pmid">23752244</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Impagnatiello</surname><given-names>F.</given-names></name><name><surname>Guidotti</surname><given-names>A. R.</given-names></name><name><surname>Pesold</surname><given-names>C.</given-names></name><name><surname>Dwivedi</surname><given-names>Y.</given-names></name><name><surname>Caruncho</surname><given-names>H.</given-names></name><name><surname>Pisu</surname><given-names>M. G.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>A decrease of reelin expression as a putative vulnerability factor in schizophrenia</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>95</volume>, <fpage>15718</fpage>–<lpage>15723</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.26.15718</pub-id><pub-id pub-id-type="pmid">9861036</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jossin</surname><given-names>Y.</given-names></name><name><surname>Bar</surname><given-names>I.</given-names></name><name><surname>Ignatova</surname><given-names>N.</given-names></name><name><surname>Tissir</surname><given-names>F.</given-names></name><name><surname>De Rouvroit</surname><given-names>C. L.</given-names></name><name><surname>Goffinet</surname><given-names>A. M.</given-names></name></person-group> (<year>2003</year>). <article-title>The reelin signaling pathway: some recent developments</article-title>. <source/>Cereb. Cortex
<volume>13</volume>, <fpage>627</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/13.6.627</pub-id><pub-id pub-id-type="pmid">12764038</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadriu</surname><given-names>B.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2012</year>). <article-title>DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67-positive neurons in the GAD67-GFP mouse brain</article-title>. <source/>J. Comp. Neurol.
<volume>520</volume>, <fpage>1951</fpage>–<lpage>1964</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23020</pub-id><pub-id pub-id-type="pmid">22134929</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobow</surname><given-names>K.</given-names></name><name><surname>Jeske</surname><given-names>I.</given-names></name><name><surname>Hildebrandt</surname><given-names>M.</given-names></name><name><surname>Hauke</surname><given-names>J.</given-names></name><name><surname>Hahnen</surname><given-names>E.</given-names></name><name><surname>Buslei</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Increased Reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>68</volume>, <fpage>356</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e31819ba737</pub-id><pub-id pub-id-type="pmid">19287316</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname><given-names>D. D.</given-names></name><name><surname>Howell</surname><given-names>J. L.</given-names></name><name><surname>Hebert</surname><given-names>B. F.</given-names></name><name><surname>Olausson</surname><given-names>P.</given-names></name><name><surname>Taylor</surname><given-names>J. R.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Assessment of cognitive function in the heterozygous reeler mouse</article-title>. <source/>Psychopharmacology (Berl)
<volume>189</volume>, <fpage>95</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-006-0530-0</pub-id><pub-id pub-id-type="pmid">16977475</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2007</year>). <article-title>DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes</article-title>. <source/>Mol. Pharmacol.
<volume>71</volume>, <fpage>644</fpage>–<lpage>653</lpage>. <pub-id pub-id-type="doi">10.1124/mol.106.030635</pub-id><pub-id pub-id-type="pmid">17065238</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2009</year>). <article-title>The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes</article-title>. <source/>Mol. Pharmacol.
<volume>75</volume>, <fpage>342</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1124/mol.108.051763</pub-id><pub-id pub-id-type="pmid">19029285</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>G.</given-names></name><name><surname>Arnaud</surname><given-names>L.</given-names></name><name><surname>Kronstad-O’Brien</surname><given-names>P.</given-names></name><name><surname>Cooper</surname><given-names>J. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Absence of Fyn and Src causes a reeler-like phenotype</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>8578</fpage>–<lpage>8586</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1656-05.2005</pub-id><pub-id pub-id-type="pmid">16162939</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacor</surname><given-names>P. N.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Auta</surname><given-names>J.</given-names></name><name><surname>Sugaya</surname><given-names>I.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>97</volume>, <fpage>3556</fpage>–<lpage>3561</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.7.3556</pub-id><pub-id pub-id-type="pmid">10725375</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levenson</surname><given-names>J. M.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Weeber</surname><given-names>E. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene</article-title>. <source/>Biochim. Biophys. Acta
<volume>1779</volume>, <fpage>422</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagrm.2008.01.001</pub-id><pub-id pub-id-type="pmid">18237558</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levenson</surname><given-names>J. M.</given-names></name><name><surname>Roth</surname><given-names>T. L.</given-names></name><name><surname>Lubin</surname><given-names>F. D.</given-names></name><name><surname>Miller</surname><given-names>C. A.</given-names></name><name><surname>Huang</surname><given-names>I. C.</given-names></name><name><surname>Desai</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>15763</fpage>–<lpage>15773</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m511767200</pub-id><pub-id pub-id-type="pmid">16606618</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lintas</surname><given-names>C.</given-names></name><name><surname>Persico</surname><given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Neocortical Reelin promoter methylation increases significantly after puberty</article-title>. <source/>Neuroreport
<volume>21</volume>, <fpage>114</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e328334b343</pub-id><pub-id pub-id-type="pmid">19952965</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W. S.</given-names></name><name><surname>Pesold</surname><given-names>C.</given-names></name><name><surname>Rodriguez</surname><given-names>M. A.</given-names></name><name><surname>Carboni</surname><given-names>G.</given-names></name><name><surname>Auta</surname><given-names>J.</given-names></name><name><surname>Lacor</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>98</volume>, <fpage>3477</fpage>–<lpage>3482</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.051614698</pub-id><pub-id pub-id-type="pmid">11248103</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus</article-title>. <source/>Neurosci. Lett.
<volume>460</volume>, <fpage>170</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2009.05.050</pub-id><pub-id pub-id-type="pmid">19477232</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Lebedeva</surname><given-names>K.</given-names></name><name><surname>Fenton</surname><given-names>E. Y.</given-names></name><name><surname>Guskjolen</surname><given-names>A.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. L. E.</given-names></name></person-group> (<year>2013</year>). <article-title>The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus</article-title>. <source/>Neuropharmacology
<volume>71</volume>, <fpage>174</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.012</pub-id><pub-id pub-id-type="pmid">23608736</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lussier</surname><given-names>A. L.</given-names></name><name><surname>Romay-Tallón</surname><given-names>R.</given-names></name><name><surname>Kalynchuk</surname><given-names>L. E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice</article-title>. <source/>Neuropharmacology
<volume>60</volume>, <fpage>1064</fpage>–<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.09.007</pub-id><pub-id pub-id-type="pmid">20849864</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maloku</surname><given-names>E.</given-names></name><name><surname>Covelo</surname><given-names>I. R.</given-names></name><name><surname>Hanbauer</surname><given-names>I.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Kadriu</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>4407</fpage>–<lpage>4411</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914483107</pub-id><pub-id pub-id-type="pmid">20150511</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrone</surname><given-names>M. C.</given-names></name><name><surname>Marinelli</surname><given-names>S.</given-names></name><name><surname>Biamonte</surname><given-names>F.</given-names></name><name><surname>Keller</surname><given-names>F.</given-names></name><name><surname>Sgobio</surname><given-names>C. A.</given-names></name><name><surname>Ammassari-Teule</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice</article-title>. <source/>Eur. J. Neurosci.
<volume>24</volume>, <fpage>2061</fpage>–<lpage>2070</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05083.x</pub-id><pub-id pub-id-type="pmid">17067303</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matrisciano</surname><given-names>F.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Gavin</surname><given-names>D. P.</given-names></name><name><surname>Nicoletti</surname><given-names>F.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain</article-title>. <source/>Mol. Pharmacol.
<volume>80</volume>, <fpage>174</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1124/mol.110.070896</pub-id><pub-id pub-id-type="pmid">21505039</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matrisciano</surname><given-names>F.</given-names></name><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Dalal</surname><given-names>I.</given-names></name><name><surname>Kadriu</surname><given-names>B.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice</article-title>. <source/>Neuropharmacology
<volume>68</volume>, <fpage>184</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.04.013</pub-id><pub-id pub-id-type="pmid">22564440</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mill</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Kaminsky</surname><given-names>Z.</given-names></name><name><surname>Khare</surname><given-names>T.</given-names></name><name><surname>Yazdanpanah</surname><given-names>S.</given-names></name><name><surname>Bouchard</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Epigenomic profiling reveals DNA-methylation changes associated with major psychosis</article-title>. <source/>Am. J. Hum. Genet.
<volume>82</volume>, <fpage>696</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.01.008</pub-id><pub-id pub-id-type="pmid">18319075</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>C. P.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Kundakovic</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Histone deacetylase inhibitors decrease reelin promoter methylation <italic>in vitro</italic></article-title>. <source/>J. Neurochem.
<volume>93</volume>, <fpage>483</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03040.x</pub-id><pub-id pub-id-type="pmid">15816871</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>S.</given-names></name><name><surname>Renfro</surname><given-names>A.</given-names></name><name><surname>Quattrocchi</surname><given-names>C. C.</given-names></name><name><surname>Sheldon</surname><given-names>M.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway</article-title>. <source/>Neuron
<volume>41</volume>, <fpage>71</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(03)00819-5</pub-id><pub-id pub-id-type="pmid">14715136</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>S.</given-names></name><name><surname>Yabut</surname><given-names>O.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>10339</fpage>–<lpage>10348</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1917-08.2008</pub-id><pub-id pub-id-type="pmid">18842893</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>J. S.</given-names></name><name><surname>Sharma</surname><given-names>R. P.</given-names></name><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Salvacion</surname><given-names>A. A.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>1749</fpage>–<lpage>1754</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409648102</pub-id><pub-id pub-id-type="pmid">15671176</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ognibene</surname><given-names>E.</given-names></name><name><surname>Adriani</surname><given-names>W.</given-names></name><name><surname>Macrì</surname><given-names>S.</given-names></name><name><surname>Laviola</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Neurobehavioural disorders in the infant reeler mouse model: interaction of genetic vulnerability and consequences of maternal separation</article-title>. <source/>Behav. Brain Res.
<volume>177</volume>, <fpage>142</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.10.027</pub-id><pub-id pub-id-type="pmid">17141885</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios-Garcia</surname><given-names>I.</given-names></name><name><surname>Lara-Vásquez</surname><given-names>A.</given-names></name><name><surname>Montiel</surname><given-names>J. F.</given-names></name><name><surname>Díaz-Véliz</surname><given-names>G. F.</given-names></name><name><surname>Sepúlveda</surname><given-names>H.</given-names></name><name><surname>Utreras</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Prenatal stress down-regulates reelin expression by methylation of its promoter and induces adult behavioral impairments in rats</article-title>. <source/>PLoS One
<volume>10</volume>:<fpage>e0117680</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0117680</pub-id><pub-id pub-id-type="pmid">25679528</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesold</surname><given-names>C.</given-names></name><name><surname>Impagnatiello</surname><given-names>F.</given-names></name><name><surname>Pisu</surname><given-names>M. G.</given-names></name><name><surname>Uzunov</surname><given-names>D. P.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>95</volume>, <fpage>3221</fpage>–<lpage>3226</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.6.3221</pub-id><pub-id pub-id-type="pmid">9501244</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesold</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>W. S.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Cortical bitufted, horizontal and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>96</volume>, <fpage>3217</fpage>–<lpage>3222</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.6.3217</pub-id><pub-id pub-id-type="pmid">10077664</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptak</surname><given-names>C.</given-names></name><name><surname>Petronis</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Epigenetic approaches to psychiatric disorders</article-title>. <source/>Dialogues Clin. Neurosci.
<volume>12</volume>, <fpage>25</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="pmid">20373664</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujadas</surname><given-names>L.</given-names></name><name><surname>Gruart</surname><given-names>A.</given-names></name><name><surname>Bosch</surname><given-names>C.</given-names></name><name><surname>Delgado</surname><given-names>L.</given-names></name><name><surname>Teixeira</surname><given-names>C. M.</given-names></name><name><surname>Rossi</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>4636</fpage>–<lpage>4649</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5284-09.2010</pub-id><pub-id pub-id-type="pmid">20357114</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>Tu</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Retardation of neurobehavioral development and reelin down-regulation regulated by further DNA methylation in the hippocampus of the rat pups are associated with maternal deprivation</article-title>. <source/>Behav. Brain Res.
<volume>217</volume>, <fpage>142</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.10.018</pub-id><pub-id pub-id-type="pmid">20974192</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razin</surname><given-names>A.</given-names></name><name><surname>Shemer</surname><given-names>R.</given-names></name></person-group> (<year>1995</year>). <article-title>DNA methylation in early development</article-title>. <source/>Hum. Mol. Genet.
<volume>4</volume>, <fpage>1751</fpage>–<lpage>1755</lpage>. <pub-id pub-id-type="pmid">8541875</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>D. S.</given-names></name><name><surname>Sheldon</surname><given-names>M.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name><name><surname>Nakajima</surname><given-names>K.</given-names></name><name><surname>Goldowitz</surname><given-names>D.</given-names></name><name><surname>Curran</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain</article-title>. <source/>Development
<volume>125</volume>, <fpage>3719</fpage>–<lpage>3729</lpage>. <pub-id pub-id-type="pmid">9716537</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>M. A.</given-names></name><name><surname>Pesold</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>W. S.</given-names></name><name><surname>Kriho</surname><given-names>V.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Pappas</surname><given-names>G. D.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>97</volume>, <fpage>3550</fpage>–<lpage>3555</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.7.3550</pub-id><pub-id pub-id-type="pmid">10725376</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J. T.</given-names></name><name><surname>Rusiana</surname><given-names>I.</given-names></name><name><surname>Trotter</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Donaldson</surname><given-names>E.</given-names></name><name><surname>Pak</surname><given-names>D. T.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Reelin supplementation enhances cognitive ability, synaptic plasticity and dendritic spine density</article-title>. <source/>Learn. Mem.
<volume>18</volume>, <fpage>558</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1101/lm.2153511</pub-id><pub-id pub-id-type="pmid">21852430</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J. T.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Trotter</surname><given-names>J. H.</given-names></name><name><surname>Rusiana</surname><given-names>I.</given-names></name><name><surname>Peters</surname><given-names>M. M.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse</article-title>. <source/>J. Psychopharmacol.
<volume>27</volume>, <fpage>386</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1177/0269881112463468</pub-id><pub-id pub-id-type="pmid">23104248</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzicka</surname><given-names>W. B.</given-names></name><name><surname>Zhubi</surname><given-names>A.</given-names></name><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection</article-title>. <source/>Mol. Psychiatry
<volume>12</volume>, <fpage>385</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001954</pub-id><pub-id pub-id-type="pmid">17264840</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satta</surname><given-names>R.</given-names></name><name><surname>Maloku</surname><given-names>E.</given-names></name><name><surname>Zhubi</surname><given-names>A.</given-names></name><name><surname>Pibiri</surname><given-names>F.</given-names></name><name><surname>Hajos</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>105</volume>, <fpage>16356</fpage>–<lpage>16361</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0808699105</pub-id><pub-id pub-id-type="pmid">18852456</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R. P.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Gavin</surname><given-names>D. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection</article-title>. <source/>Schizophr. Res.
<volume>98</volume>, <fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2007.09.020</pub-id><pub-id pub-id-type="pmid">17961987</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shifman</surname><given-names>S.</given-names></name><name><surname>Johannesson</surname><given-names>M.</given-names></name><name><surname>Bronstein</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>S. X.</given-names></name><name><surname>Collier</surname><given-names>D. A.</given-names></name><name><surname>Craddock</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women</article-title>. <source/>PLoS Genet.
<volume>4</volume>:<fpage>e28</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0040028</pub-id><pub-id pub-id-type="pmid">18282107</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stranahan</surname><given-names>A. M.</given-names></name><name><surname>Salas-Vega</surname><given-names>S.</given-names></name><name><surname>Jiam</surname><given-names>N. T.</given-names></name><name><surname>Gallagher</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Interference with reelin signaling in the lateral entorhinal cortex impairs spatial memory</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>96</volume>, <fpage>150</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2011.03.009</pub-id><pub-id pub-id-type="pmid">21492744</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>V.</given-names></name><name><surname>Fasching</surname><given-names>D.</given-names></name><name><surname>Hauser</surname><given-names>C.</given-names></name><name><surname>Mayer</surname><given-names>H.</given-names></name><name><surname>Bock</surname><given-names>H. H.</given-names></name><name><surname>Hiesberger</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Receptor clustering is involved in Reelin signaling</article-title>. <source/>Mol. Cell Biol.
<volume>24</volume>, <fpage>1378</fpage>–<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.24.3.1378-1386.2004</pub-id><pub-id pub-id-type="pmid">14729980</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>B.-M.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of perinatal hypothyroidism on regulation of reelin and brain-derived neurotrophic factor gene expression in rt hippocampus: role of DNA methylation and histone acetylation</article-title>. <source/>Steroids
<volume>75</volume>, <fpage>988</fpage>–<lpage>997</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2010.06.005</pub-id><pub-id pub-id-type="pmid">20600205</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ju</surname><given-names>L.-H.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long term potentiation in rat medial prefrontal cortex</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>97</volume>, <fpage>425</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2012.03.007</pub-id><pub-id pub-id-type="pmid">22469747</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szyf</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Epigenetics, DNA methylation and chromatin modifying drugs</article-title>. <source/>Annu. Rev. Pharmacol. Toxicol.
<volume>49</volume>, <fpage>243</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pharmtox-061008-103102</pub-id><pub-id pub-id-type="pmid">18851683</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tochigi</surname><given-names>M.</given-names></name><name><surname>Iwamoto</surname><given-names>K.</given-names></name><name><surname>Bundo</surname><given-names>M.</given-names></name><name><surname>Komori</surname><given-names>A.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Methylation status of the reelin promoter region in the brain of schizophrenia subjects</article-title>. <source/>Biol. Psychiatry
<volume>63</volume>, <fpage>530</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2007.07.003</pub-id><pub-id pub-id-type="pmid">17870056</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><name><surname>Carboni</surname><given-names>G.</given-names></name><name><surname>Ruzicka</surname><given-names>W. B.</given-names></name><name><surname>Mitchell</surname><given-names>C. P.</given-names></name><name><surname>Sugaya</surname><given-names>I.</given-names></name><name><surname>Tueting</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>99</volume>, <fpage>17095</fpage>–<lpage>17100</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.262658999</pub-id><pub-id pub-id-type="pmid">12481028</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><name><surname>Doueiri</surname><given-names>M. S.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name><name><surname>Pinna</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice</article-title>. <source/>Biol. Psychiatry
<volume>57</volume>, <fpage>500</fpage>–<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.11.046</pub-id><pub-id pub-id-type="pmid">15737665</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trommsdorff</surname><given-names>M.</given-names></name><name><surname>Gotthardt</surname><given-names>M.</given-names></name><name><surname>Hiesberger</surname><given-names>T.</given-names></name><name><surname>Shelton</surname><given-names>J.</given-names></name><name><surname>Stockinger</surname><given-names>W.</given-names></name><name><surname>Nimpf</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2</article-title>. <source/>Cell
<volume>97</volume>, <fpage>689</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80782-5</pub-id><pub-id pub-id-type="pmid">10380922</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><name><surname>Dwivedi</surname><given-names>Y.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Impagnatiello</surname><given-names>F.</given-names></name><name><surname>Manev</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>The phenotypic characteristics of heterozygous reeler mouse</article-title>. <source/>Neuroreport
<volume>10</volume>, <fpage>1329</fpage>–<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199904260-00032</pub-id><pub-id pub-id-type="pmid">10363948</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Pibiri</surname><given-names>F.</given-names></name><name><surname>Kadriu</surname><given-names>B.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>L-methionine decreases dendritic spine density in mouse frontal cortex</article-title>. <source/>Neuroreport
<volume>21</volume>, <fpage>543</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e3283373126</pub-id><pub-id pub-id-type="pmid">20442623</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tueting</surname><given-names>P.</given-names></name><name><surname>Doueiri</surname><given-names>M. S.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Reelin down-regulation in mice and psychosis endophenotypes</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>30</volume>, <fpage>1065</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2006.04.001</pub-id><pub-id pub-id-type="pmid">16769115</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Caruncho</surname><given-names>H. J.</given-names></name><name><surname>Liu</surname><given-names>W. S.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name><name><surname>Satta</surname><given-names>R.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>101</volume>, <fpage>348</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2637013100</pub-id><pub-id pub-id-type="pmid">14684836</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Kadriu</surname><given-names>B.</given-names></name><name><surname>Maloku</surname><given-names>E.</given-names></name><name><surname>Agis-Balboa</surname><given-names>R. C.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Costa E. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder</article-title>. <source/>Schizophr. Res.
<volume>91</volume>, <fpage>51</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2006.11.029</pub-id><pub-id pub-id-type="pmid">17270400</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventruti</surname><given-names>A.</given-names></name><name><surname>Kazdoba</surname><given-names>T. M.</given-names></name><name><surname>Niu</surname><given-names>S.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain</article-title>. <source/>Neuroscience
<volume>189</volume>, <fpage>32</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.05.050</pub-id><pub-id pub-id-type="pmid">21664258</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Hong</surname><given-names>Y.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name><name><surname>Zhong</surname><given-names>R.</given-names></name><name><surname>Zhu</surname><given-names>B.</given-names></name><name><surname>Shen</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Reelin gene variants and risk of autism spectrum disorders: an integrated meta-analysis</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>165B</volume>, <fpage>192</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32222</pub-id><pub-id pub-id-type="pmid">24453138</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>I. C.</given-names></name><name><surname>Champagne</surname><given-names>F. A.</given-names></name><name><surname>Brown</surname><given-names>S. E.</given-names></name><name><surname>Dymov</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Meaney</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>11045</fpage>–<lpage>11054</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3652-05.2005</pub-id><pub-id pub-id-type="pmid">16306417</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>I. C.</given-names></name><name><surname>Meaney</surname><given-names>M. J.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>103</volume>, <fpage>3480</fpage>–<lpage>3485</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0507526103</pub-id><pub-id pub-id-type="pmid">16484373</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wedenoja</surname><given-names>J.</given-names></name><name><surname>Tuulio-Henriksson</surname><given-names>A.</given-names></name><name><surname>Suvisaari</surname><given-names>J.</given-names></name><name><surname>Loukola</surname><given-names>A.</given-names></name><name><surname>Paunio</surname><given-names>T.</given-names></name><name><surname>Partonen</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Replication of association between working memory and Reelin, a potential modifier gene in schizophrenia</article-title>. <source/>Biol. Psychiatry
<volume>67</volume>, <fpage>983</fpage>–<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.026</pub-id><pub-id pub-id-type="pmid">19922905</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>R. J.</given-names></name><name><surname>Benedict</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>J.</given-names></name></person-group> (<year>1971</year>). <article-title>Biochemical and sleep studies of schizophrenia: a review of the literature-1960–1970</article-title>. <source/>Schiz. Bull.
<volume>4</volume>, <fpage>10</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/1.4.10</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Mundo</surname><given-names>E.</given-names></name><name><surname>Macciardi</surname><given-names>F.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Reelin gene alleles and susceptibility to autism spectrum disorders</article-title>. <source/>Mol. Psychiatry
<volume>7</volume>, <fpage>1012</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001124</pub-id><pub-id pub-id-type="pmid">12399956</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhubi</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Dong</surname><given-names>E.</given-names></name><name><surname>Cook</surname><given-names>E. H.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum</article-title>. <source/>Transl. Psychiatry
<volume>4</volume>:<fpage>e349</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2013.123</pub-id><pub-id pub-id-type="pmid">24448211</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>